Your browser doesn't support javascript.
loading
Characterization of primary hyperparathyroidism based on target organ involvement: An analysis from the Indian PHPT registry.
Mukherjee, Soham; Arya, Ashutosh K; Bhadada, Sanjay Kumar; Pal, Rimesh; Lohani, Shivangani; Gupta, Ashish; Rao, Sudhaker D.
Affiliation
  • Mukherjee S; Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Arya AK; Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
  • Bhadada SK; Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Pal R; Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Lohani S; Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Gupta A; Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Rao SD; Bone and Mineral research Laboratory, Henry Ford Health, Detroit, Michigan, USA.
Clin Endocrinol (Oxf) ; 99(2): 158-164, 2023 08.
Article in En | MEDLINE | ID: mdl-36998119
ABSTRACT

BACKGROUND:

It has been a matter of debate for long time about the existence of two distinct phenotypes of primary hyperparathyroidism (PHPT) predisposed to either renal or skeletal manifestation.

OBJECTIVE:

To differentiate characteristics of symptomatic PHPT patients based on the presence of skeletal or renal involvement.

DESIGN:

Retrospective analysis of data from the Indian PHPT registry. PATIENTS PHPT patients were divided into four discrete groups asymptomatic, presenting with renal manifestations alone, skeletal manifestations alone, and both skeletal and renal manifestations. MEASUREMENTS Clinical, biochemical, and tumour weight and histopathological characteristics of these groups were compared.

RESULTS:

Of the 229 eligible patients, 45 were asymptomatic, 62 had renal manifestations, 55 had skeletal manifestations, and 67 had both skeletal and renal manifestations. Patients with both skeletal and renal manifestations had higher serum calcium levels than those with isolated skeletal involvement [12.5 (11.1-13.7) mg/dL, 11.2 (10.6-12.3) mg/dL, respectively; p < .05]. Serum alkaline phosphatase (AP), plasma parathyroid hormone (PTH) levels, and parathyroid tumour weight were significantly higher in patients with isolated skeletal, and both skeletal and renal manifestations, compared to the other two groups. A preoperative PTH and AP level of 300 pg/mL and 152 U/L, predicted the risk of developing skeletal involvement with sensitivity and specificity of 71%, 70%, and 69%, 67%, respectively.

CONCLUSIONS:

We observed distinct skeletal and renal phenotypic subgroups among PHPT patients with characteristic biochemical and hormonal patterns with higher parathyroid disease burden in patients with skeletal complications compared to those with isolated renal manifestation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcium / Hyperparathyroidism, Primary Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Endocrinol (Oxf) Year: 2023 Type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcium / Hyperparathyroidism, Primary Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Endocrinol (Oxf) Year: 2023 Type: Article Affiliation country: India